Figure 3From: Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria in the setting of three different chemopreventive regimens Cumulative risk of recurrent malaria within 84 days of treatment with artemether-lumefantrine (AL) stratified by pre-treatment piperaquine levels. Back to article page